Cresco Labs Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Charles Bachtell
- Full Time Employees
- 2,900
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 400 West Erie Street Chicago IL United States of America 60654
- IPO Date
- Dec 3, 2018
- CIK
- 0001832928
- Website
- crescolabs.com
- Similar Companies
- Business
- Cresco Labs Inc. (CRLBF) operates as a vertically integrated multistate cannabis company that cultivates, manufactures, and sells retail and medical cannabis products across the United States and internationally; it offers a portfolio of branded products including premium flower, vape pens, live resins, disposable pens, extracts, pre-rolls, concentrates, popcorn, shake, gummies, edibles, tinctures, capsules, salves, and sublingual oils under brands such as Cresco, High Supply, FloraCal, Good News, Wonder Wellness Co., Mindys Edibles, Remedi, Sunnyside Chews, and licensed Kiva; the company also runs Sunnyside dispensaries focused on consumer education, trust, and convenience, with wholesale distribution emphasizing national availability. Founded in 2013 and headquartered in Chicago, Illinois, Cresco Labs maintains operations in eight U.S. states targeting both recreational and medical consumers through cultivation, production, and retail channels, while extending into Germany via pharmacy-distributed flower products. In 2025, the company refinanced its senior secured credit facility with a $325 million term loan maturing in 2030 at 12.5% interest to strengthen its balance sheet and support growth, and launched its flagship Cresco-branded flower products in the European Union market through a partnership with Portugal-based Blossom, an EU GMP-certified manufacturer, marking its first international expansion beyond the U.S.
Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration
Cresco Labs Inc. (CRLBF) Upgraded to Buy: Here's Why
Cresco Labs Provides Update on Texas License Previously Awarded by Texas Department of Public Safety
Cresco Labs Inc. (CRLBF) Q1 2026 Earnings Call Transcript
Cresco Labs Inc. (CRLBF) Reports Q1 Loss, Beats Revenue Estimates
Cresco Labs Reports First Quarter 2026 Financial Results, Advances Multiple Growth Initiatives
Why Fast-paced Mover Cresco Labs Inc. (CRLBF) Is a Great Choice for Value Investors
Cresco Labs Opens Sunnyside Aberdeen, Marking Second Ohio Dispensary Opening in a Month
Top Marijuana Stocks and Investment Outlook 2026
Marijuana Stocks: Industry Growth, Rescheduling Impact, and Outlook
The Cannabis Sector's Billion-Dollar Tax Cut
Cresco Labs CEO: Rescheduling Ushers in a New Era of Care for Medical Cannabis Patients
Cresco Labs to Report First Quarter 2026 Financial Results on May 8, 2026
3 Marijuana Stocks To Watch In 2026 For Better Trading
Top U.S. Marijuana Stocks to Watch as Cannabis Reform Gains Momentum
Cresco Labs Opens Sunnyside Bridgeport, Expanding Access in the Ohio Valley
Best U.S. Cannabis Stocks for April 2026: Growth, Scale, and Opportunity
Cresco Labs Awarded Texas Medical Cannabis License
Bloom Expands Partnership with Cresco Labs to Enter Pennsylvania's Vape-Forward Medical Market
3 Marijuana Stocks To Build A Stronger Portfolio